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Abstract
Purpose To examine the natural course and outcome of
major depressive disorder (MDD) in primary care over
39 months.
Methods Prospective cohort study of 1,338 consecutive
attendees with follow-up after 6, 12, and 39 months with
DSM-IV MDD using the Composite International Diag-
nostic Interview (CIDI). We measured severity of depres-
sive symptoms (Patient Health Questionnaire 9), somatic
symptoms (Patient Health Questionnaire 15), and mental
and physical function (Short Form 12, mental and physical
component summary). Analysis of variance and random
coefﬁcient models were performed.
Results At baseline, 174 people (13%) had MDD of
which 17% had a chronic and 40% had a ﬂuctuating course,
while 43% remitted. Patients with chronic courses had
more severe depressive symptoms (mean difference 6.54;
95% CI 4.38–8.70), somatic symptoms (mean difference
3.31; 95% CI 1.61–5.02), and greater mental dysfunction
(mean difference -10.49; 95% CI -14.42 to -6.57) at
baseline than those who remitted from baseline, indepen-
dent of age, sex, level of education, presence of a chronic
disease, and a lifetime history of depression.
Conclusions Although 43% of patients with MDD
attending primary care recover, this leaves a majority of
patients (57%) who have a chronic or intermittent course.
Chronic courses are associated with higher levels of depres-
sive symptoms and somatic symptoms and greater mental
dysfunction at baseline.
Keywords Depression  General practice  Symptoms 
Function  Epidemiology
Introduction
Major depressive disorder (MDD) is a serious health
problem and will be the second leading cause of burden
of disease worldwide by 2030 [1]. In any given 12-month
period, 10–20% of adults will visit their general practi-
tioner (GP) for mental complaints, of which the majority
are related to depression [2]. The prevalence of MDD in
primary care is estimated to be between 4 and 18% [3].
People presenting with depressive symptoms are mainly
seen in primary care; however, treatment guidelines are
mainly based upon data from hospital settings or the
general population [4]. Few studies have examined the
course and outcome of MDD in primary care over a
greater period of time. In one study, 32% of the primary
care patients who were depressed at baseline were not
depressed after 12 months and 47% were not depressed
after 3.5 years [5]. A recent study showed that of the 79
primary care patients diagnosed with MDD at baseline,
25% persisted and 49% suffered from residual symptoms
or recurrences after 18 months [6]. These data suggest
that the majority of adult patients with depression in
primary care do not recover in the medium-term, but also
that some patients do recover.
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primary care included small sample sizes and had a short
duration of follow-up [4, 7]. The nature of depression can
be complex: symptoms can improve and deteriorate over
time and patients can switch between depression categories
[4]. However, this ﬂuctuating course of depression can be
missed in studies with a short duration of follow-up or few
assessments [8]. A recent review showed that between
1985 and 2006 only two observational studies in primary
care were performed with a follow-up longer than one year
[4]. These studies included three assessments of depression
at most.
The objective of this study was to examine the natural
course of MDD in primary care attendees over a period of
39 months. We investigated the course of major depression
and its relationship to the severity of depressive and
somatic symptoms, and mental and physical function in a
cohort of primary care attendees aged 18 years or older
who were diagnosed with MDD at baseline.
Methods
Study setting and design
PredictD is a multicenter prospective cohort study from
which a multifactor algorithm was developed to predict
risk of onset of MDD in primary care patients in six
European countries and Chile [3, 9–11]. In brief, in 2003,
consecutive adult primary care patients were asked to
participate, irrespective of their reasons for consulting their
general practitioners. Patients were followed-up after 6 and
12 months. The current study used data from PREDICT-
NL, the Dutch part of PredictD, in which an additional
follow-up after 39 months was conducted. The study was
approved by the medical ethics committee of the Univer-
sity Medical Center Utrecht and was conducted in seven
large general practice centres near Utrecht.
Study participants
Consecutive attendees aged 18 years or older were
recruited and interviewed between April 2003 and Sep-
tember 2004. Patients willing to participate were asked to
ﬁll in risk factor questionnaires and sign informed consent
within 2 weeks. After the risk factor questionnaires were
returned, an appointment was made by the researchers to
conduct a diagnostic depression interview at the general
practice. If patients did not respond after 2 weeks, a ﬁrst
reminder was sent and, if necessary, a second reminder
after 4 weeks. Participants who did not respond to the
second reminder were considered to be non-responders. All
participants gave written informed consent.
Diagnosis of major depressive disorder
The diagnosis of MDD was assessed in all patients
according to DSM-IV criteria using the depression section
of the Composite International Diagnostic Interview (CIDI)
[12, 13]. The researchers contacted the participant by
telephone and asked the two core questions of the
depression section of the CIDI interview (depressed mood
or a loss of interest). MDD was deﬁned as absent if the
participant responded negatively to both questions [12]. If
the participant responded positively to either question, an
appointment was made in the general practice to conduct
the entire depression section of the CIDI interview. The
interviewers were blinded to the answers on the risk factor
questionnaires. At baseline, the 6- and 12-month follow-up,
diagnosis of MDD was assessed covering the preceding
6 months. At the 39-month follow-up, diagnosis of MDD
was assessed covering the period between the 12- and 39-
month follow-up. If the participant was unable to schedule
the interview at the general practice, the interview was
done through telephone (23% of interviews at baseline,
17% at the 6-month follow-up, and 19% at the 12-month
follow-up). At the 39-month follow-up, all interviews were
through telephone. Several studies have shown that both
methods are comparable with respect to validity and reli-
ability [14].
Outcome measures
Severity of depressive symptoms
The self-report Patient Health Questionnaire 9 (PHQ-9)
was included with the risk factor questionnaires [15]. It
assesses the presence in the past 2 weeks of the nine DSM-
IV criteria for MDD on a 4-point rating scale, ranging from
0 (‘‘not at all’’) to 3 (‘‘nearly every day’’). The scores on
this questionnaire range from 0 to 27.
Severity of somatic symptoms
Severity of somatic symptoms was assessed by the PHQ-
15, which inquires about 15 somatic symptoms in the
preceding 4 weeks: (1) stomach pain, (2) back pain, (3)
pain in your arms, legs, or joints, (4) menstrual cramps or
other problems with your periods (women only), (5)
headaches, (6) chest pain, (7) dizziness, (8) fainting spells,
(9) feeling your heart pound or race, (10) shortness of
breath, (11) pain or problems during sexual intercourse,
(12) constipation, loose bowels, or diarrhoea, (13) nausea,
gas, or indigestion, (14) feeling tired or having low energy,
and (15) trouble sleeping [16]. It uses a 3-point rating scale,
ranging from 0 (‘‘not bothered at all’’) to 2 (‘‘bothered a
lot’’). The scores on this questionnaire range from 0 to 30.
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Mental and physical functions were assessed by the Short
Form 12 (SF-12 MCS and PCS) [17]. The SF-12 is derived
from the SF-36, both of which have been widely used in
primary care settings. The SF-12 yields a scale from 0 to
100, in which lower scores indicate greater dysfunction.
Other variables
Patient characteristics were obtained at baseline using self-
report questionnaires and included age, sex, employment
status (employed or unemployed), marital status (living
with or without a partner), educational level (11-point
ordinal scale ranging from ‘no education’ to ‘PhD-level’,
categorized into lower, middle, and higher level of edu-
cation), number of life events (no, one, or two or more
events), and presence of one or more chronic diseases
diagnosed by a physician [18]. Lifetime depression was
based on afﬁrmative answers to both of the ﬁrst two
questions of the CIDI depression section [19].
Data analysis
Missing data rarely occurs completely at random and a
complete case analysis may lead to loss of statistical power
and to biased results [20]. We, therefore, used multiple
imputations to address missing data which were imputed at
baseline, at the 6-, 12-, and 39-month follow-up separately
[21]. At each time-point 10 datasets were generated and all
variables mentioned above were used as predictors. We
compared results obtained by analysing with and without
imputation to observe the extent of imputation used.
First, baseline characteristics before imputation for par-
ticipants with and without MDD were presented as means
with standard deviations (SD) for continuous variables and
numbers with percentages for categorical variables, and
tested with F-tests (ANOVA) and the Chi-squared tests,
respectively. Missing data for each covariate at baseline are
presented.
Second, a ﬂowchart was created to describe the course
of participants with MDD at baseline. At each assessment,
we calculated the number of lost to follow-up. The ﬂow-
charts categorized participants into different courses. We
deﬁned the following three courses: (1) patients who were
in remission from baseline (remitted); (2) patients who had
a ﬂuctuating MDD course (intermittent); and (3) patients
who had MDD at all four assessments (chronic).
Third, for each outcome variable (PHQ-9, PHQ-15, SF-
12 MCS, and PCS) separate analysis of variance
(ANOVA) was performed with the scores at each
assessment as dependent and the course groups as inde-
pendent variable. We used ANOVA analyses to test for
differences in mean symptom or function score among
each course group.
Fourth, SAS PROC MIXED was used in random coef-
ﬁcient analyses (RCA) with robust standard errors, to
estimate the change in depressive symptoms, somatic
symptoms, mental function, and physical function over
time for each course group. We used random intercept and
slope for best model ﬁt. The courses and time, and the
interaction between course group and time were entered as
independent variables and the outcome measure was
entered as the dependent variable. The coefﬁcients of
interaction between the course groups and time represent
the change of symptom or function over time as a function
of the course group. The time between the follow-up
assessments was computed for each person individually.
Age, sex, education level, presence of a chronic disease,
and lifetime depression were added to the models to control
for potential confounding. Analyses were performed using
PASW version 17 (IBM SPSS Statistics) and SAS version
9.1 (SAS institute).
Results
In total, 3,089 patients were asked to take part in the study,
of which 83 did not meet inclusion criteria. Seventy-ﬁve
were not ﬂuent in Dutch, ﬁve had dementia, two had
psychosis, and one had severe learning disabilities. Of the
remaining 3,006 patients, 1,338 (44.5%) consented and
took part in the study, while 915 (30%) actively refused.
Reasons for not participating were mostly lack of time
(21%, N = 192) and no interest (24%, N = 224). Refusal
without reason was present in 249 (8%) with and 504
(16%) without demographic information. Of the 1,164
refusals on whom we had demographic information, we
found no difference in the age (mean 51 years, SD 19) and
sex (62% female) distribution when compared to our par-
ticipants. The numbers lost to follow-up throughout the
study period were similar amongst participants who were
depressed at baseline (74/174, 43%) and those who were
not depressed (504/1,164, 43%). Participants who were lost
to follow-up were similar in age and sex distribution,
baseline PHQ-9, PHQ-15, SF-12 MCS, and PCS scores to
those who were retained in the study.
Of the 1,338 participants, 1,266 (95%) participated at
the 6-month follow-up, and 1,206 (95% of 1,266) at
12 months. At 39 months, 1,133 participants were invited
to take part, because 72 participants withdrew from the
study and one participant died. Of the 1,133 invited par-
ticipants, 759 participants consented to take part (67%).
The mean durations of follow-up in months were 5.7 (SD
0.6) at the 6-month follow-up, 12.0 (SD 0.6) at 12 months
and 39.2 (SD 2.3) at 39 months. The cohort was mainly
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and most of them were living with a partner (75%)
(Table 1).
After imputation of missing values, at baseline the
prevalence of MDD over the previous 6 months was 13.0%
(N = 174), 9.0% (N = 115) at 6 months, and 5.5%
(N = 67) at 12 months. At 39 months, 11.8% (N = 90)
had MDD in the period between 12- and 39-months
assessment. Of the 174 participants who were depressed at
baseline, 100 were followed up at all three time points
(Fig. 1). As much as 43% of the participants with MDD at
baseline were in remission from baseline, 40% had a
ﬂuctuating course of depression, while 17% were chroni-
cally depressed over the 39 months of the study (Table 2).
We present unadjusted mean depressive and somatic
symptom levels at each assessment for the three course
groups in Figs. 2 and 3, and mean mental and physical
function scores in Figs. 4 and 5. Participants with a chronic
course of disease had a higher level of depressive and
somatic symptoms and greater mental and physical dys-
function over time compared to the other courses. How-
ever, the difference of physical function among all courses
over time was little. Participants who remitted from base-
line had a lower level of depressive and somatic symptoms
and less mental dysfunction over time when compared to
the other course groups. Complete case analysis before
imputation for PHQ-9 (N = 75), PHQ-15 (N = 79), SF-12
MCS, and PCS (both N = 64) revealed similar results.
Severity of depressive and somatic symptoms decreased
and mental function increased over time in participants
with MDD at baseline (Table 3). When compared to par-
ticipants who remitted from baseline, people with a chronic
course had signiﬁcantly higher levels of depressive and
somatic symptoms and greater mental dysfunction at
baseline, after adjustment for age, sex, education, presence
of a chronic disease, and lifetime depression. The severity
of symptoms and function for those with a chronic course
did not signiﬁcantly change over time compared to those
who were in remission from baseline. Physical function
was similar in all course groups. Analysis before imputa-
tion (N = 85) for PHQ-9, PHQ-15, SF-12 MCS, and PCS
did affect the estimates, but did not lead to other
conclusions.
Discussion
Our study examined the natural course and outcome of
MDD in adult primary care attendees. We observed that
17% of participants with MDD at baseline continued to be
depressed after 39 months, and another 40% had a ﬂuctu-
ating course of depression, while 43% were in remission
Table 1 Baseline characteristics for the participants with and without major depressive disorder
Total (N = 1,318)
a MDD (N = 174) No MDD (N = 1,144) Missing (N)
Age in years, mean (SD) 51 (17) 46 (14) 52 (17) 0
Female, N (%) 828 (63) 125 (72) 703 (62) 0
Employed, N (%) 728 (58) 97 (59) 631 (58) 64
Living with partner, N (%) 967 (75) 110 (64) 857 (76) 23
Education level
b, N (%) 25
Lower 298 (23) 50 (29) 248 (22)
Middle 600 (46) 73 (43) 527 (47)
Higher 395 (31) 48 (28) 347 (31)
Life events, N (%) 16
No 511 (39) 39 (23) 472 (42)
One 359 (28) 37 (22) 322 (28)
Two or more 432 (33) 96 (55) 336 (30)
Presence of a chronic disease, N (%) 558 (44) 78 (46) 480 (43) 36
Lifetime depression, N (%) 425 (34) 108 (67) 317 (29) 57
PHQ-9 score, mean (SD) 4 (5) 10 (6) 3 (4) 42
PHQ-15 score, mean (SD) 6 (4) 10 (4) 6 (4) 37
SF-12 MCS, mean (SD) 48 (11) 32 (9) 50 (9) 195
SF-12 PCS, mean (SD) 47 (10) 47 (11) 47 (10) 195
MDD major depressive disorder, SD standard deviation, PHQ patient health questionnaire, SF short form, MCS mental component summary,
PCS physical component summary
a Missing values, N = 20
b Lower = No education or primary school, Middle = Secondary school, Higher = Above secondary school
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had more depressive and somatic symptoms and greater
mental dysfunction at baseline, independent of age, sex,
level of education, presence of a chronic disease, and
lifetime depression compared to those who remitted from
baseline.
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Fig. 1 Flowchart with courses and attrition for participants with major depressive disorder at baseline (N = 174)
Table 2 Numbers with major depressive disorder at baseline in each
subgroup (N = 174)
Course group 0 6 12 39 N %
Remitted 43 43
Remitted from baseline ? –– –
Intermittent 40 40
No MDD at 39 months, intermittent
course
? – ? –
No MDD at 39 months, intermittent
course
??––
No MDD at 39 months, intermittent
course
??? –
MDD at 39 months, intermittent course ? –– ?
MDD at 39 months, intermittent course ??– ?
MDD at 39 months, intermittent course ? – ??
Chronic 17 17
MDD at all assessments ??? ?
Total 100 100
Lost to follow-up 74
0, 6, 12, and 39 represent time points when assessment of MDD was
made (in months)
? Presence of MDD, – Absence of MDD
MDD major depressive disorder
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Fig. 2 Unadjusted mean depressive symptom scores (PHQ-9) at each
assessment for each of the three courses
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123To our knowledge, this is one of the few observational
studies on the natural course of MDD in primary care
attendees with a medium-term follow-up and more than
two assessments. Previous work is mainly restricted to
specialty mental health care clinics or general population
samples despite the fact that most people with depression
and anxiety are managed in primary care [22]. Unlike
previous research, our study had a relatively long follow-up
period during which we conducted several assessments.
Furthermore, we had a medium-sized sample of 174 per-
sons with MDD at baseline which we diagnosed using
DSM-IV criteria rather than relying on cross-sectional
questionnaires.
However, our study was limited by low response rates
at baseline, although similar participation rates have been
found in other observational studies in primary care [10,
23]. This could be partly explained by the fact that people
were recruited to the study by researchers in the waiting
room rather than by the consulting physicians. Given the
relatively high prevalence of MDD at baseline, it is
possible that persons with MDD were more willing to
participate. Nevertheless, loss to follow-up was extremely
low during the ﬁrst 12 months, and during the entire
follow-up period loss to follow-up in those depressed or
not depressed at baseline was similar. Second, the time
between 12 and 39 months was longer than in between
the other assessments. Consequently, participants were
asked about their symptoms retrospectively in the pre-
ceding 2 years and 3 months during the ﬁnal follow-up,
which might have been less reliable than for the other
follow-up assessments. Third, since we did not have data
on treatments received for depression we could not ana-
lyse the inﬂuences of these on the course of the illness.
Nevertheless, these results still reﬂect the longitudinal
history of MDD in people seen in general practice over
time. Fourth, primary care is not uniformly organized in
all countries, so these ﬁndings might not be generalizable
to all countries.
The majority of participants who were diagnosed with
MDD at baseline had an intermittent or chronic course of
disease. Our ﬁndings are concordant with several com-
munity-based studies with follow-up durations ranging
from 2 to 49 years in adults diagnosed with MDD showing
that about 20% developed a chronic course and about
30–50% had a recurrent course [24–29]. Our ﬁndings
suggest that the natural history of depression in primary
care resembles that of depression in the general adult
population.
As much as 57% of patients diagnosed with MDD at
baseline had not recovered after 39 months, which is
consistent with ﬁndings from a study in primary care
with three assessments, where 53% of the adult popu-
lation diagnosed with MDD at baseline had not recov-
ered after 3.5 years, in which partial remission rather
than full recovery was the rule [5, 30]. Two methodo-
logical differences between their study and the present
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Fig. 3 Unadjusted mean somatic symptom scores (PHQ-15) at each
assessment for each of the three courses
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Fig. 4 Unadjusted mean mental function scores (SF-12 MCS) at each
assessment for each of the three courses
0
10
20
30
40
50
60
0 6 12 18 24 30 36
Time (months)
P
h
y
s
i
c
a
l
 
f
u
n
c
t
i
o
n
 
(
S
F
-
1
2
 
P
C
S
)
Remitted (N=43)
Intermittent (N=40)
Chronic (N=17)
Fig. 5 Unadjusted mean physical function scores (SF-12 PCS) at
each assessment for each of the three courses
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123study are noteworthy. First, the latter study used a two-
stage design in which consecutive primary care attendees
were screened on psychiatric illness by their consulting
physicians and by the researchers using the General
Health Questionnaire (GHQ). Subsequently, a stratiﬁed
random sample was selected for the baseline examination
on the basis of the outcome of this GP and GHQ screening.
In our study, consecutive primary care attendees were
included irrespective of their reasons for consulting the GP.
Second, those who were included in the study by Ormel
et al. were diagnosed using the Present State Examination
(PSE), while we diagnosed MDD using the CIDI. Dis-
ability was measured by the Groningen Social Disability
Schedule (SDS) in their study compared to the SF-12 used
in our study. We have built on their study by including a
larger sample of primary care attendees, who were included
irrespective of their reason for consultation. Although the
methods employed in our study were somewhat different,
the results were generally comparable and support the
ﬁnding that the majority of those diagnosed with MDD
have a poor course. As much as 17% in our study had
MDD at all assessments, which is lower than results from a
primary care study of 160 patients diagnosed with MDD at
baseline, of which 32% had not recovered at 3 years [31].
However, the latter study was performed in a sample of
older people making direct comparisons difﬁcult. Recent
primary care-based studies revealed that about 50% of
depressed adolescents failed to recover after 6 months,
while 74% of depressed adults had not recovered after
18 months [6, 32]. In addition, the recurrence rate of pri-
mary care depression may be up to 64% over a period of
23 years [33].
Participants with a chronic course had more depressive
and somatic symptoms and greater mental dysfunction at
baseline than those remitted from baseline. Baseline
severity of depression is a risk factor for persistence in the
short-term, as shown by other studies, but our ﬁndings
suggest that it is also a risk factor for persistence in the
medium-term, even independent of a depression history
[34, 35]. The latter has also recently been shown by a
primary care study which followed recurrent depressive
patients for 3 years, and our results underline these ﬁndings
[36]. The study by Ormel et al. [5] reported that patients
with depression who had higher levels of disability
improved considerably over time, although residual dis-
ability was present in some cases. A relationship between
somatic symptoms and depression, and between mental
dysfunction and depression severity has been found in
cross-sectional studies in primary care, but our results add
to the current knowledge that high levels of somatic
symptoms and greater mental dysfunction at baseline are
possible risk factors for persistence of depression over
39 months [37, 38]. Within the chronic group, the level of
depressive and somatic symptoms and mental functioning
did not change over time compared to those who remitted
from baseline, suggesting that those who are depressed and
have higher symptom levels or lower levels of function at
baseline are likely to persist in higher levels of symptoms
and lower levels of function over the course of 39 months.
Findings from the current study suggest that for those
attending primary care, a higher severity of depressive or
somatic symptoms, or lower levels of mental function may
be an indication of a poor course of MDD. The pattern of
depressive and somatic symptoms over time for the course
Table 3 Random coefﬁcient analyses for all course groups and outcome variables (N = 100)
PHQ-9 PHQ-15 SF-12 MCS SF-12 PCS
b 95% CI b 95% CI b 95% CI b 95% CI
Intercept 2.90 -0.69 to 6.49 4.97 1.13 to 8.81 45.46 38.81 to 52.12 53.48 41.42 to 65.54
Time
a -0.12 -0.16 to -0.08 -0.09 -0.11 to -0.06 0.29 0.19 to 0.39 0.04 -0.05 to 0.14
Remitted (ref) 0 0 0 0
Intermittent 3.23 1.49 to 4.98 0.83 -0.44 to 2.10 -2.97 -6.34 to 0.40 1.28 -2.51 to 5.10
Chronic 6.54 4.38 to 8.70 3.31 1.61 to 5.02 -10.49 -14.42 to -6.57 -0.87 -5.70 to 3.97
Time 9 Remitted (ref) 0 0 0 0
Time 9 Intermittent 0.03 -0.03 to 0.09 0.03 -0.01 to 0.06 -0.11 -0.26 to 0.04 -0.06 -0.19 to 0.06
Time 9 Chronic -0.01 -0.08 to 0.07 0.03 -0.04 to 0.09 0.01 -0.17 to 0.18 -0.02 -0.19 to 0.14
Female 1.62 0.44 to 2.79 2.31 1.06 to 3.55 -2.61 -4.70 to -0.52 -2.13 -5.83 to 1.58
Presence of a chronic disease 2.51 1.38 to 3.65 2.77 1.69 to 3.84 -3.69 -5.83 to 1.54 -7.29 -10.54 to -4.03
Models are adjusted for age, sex, education, presence of a chronic disease, and lifetime depression. Age, education and lifetime depression were
not statistically signiﬁcant and are therefore not presented
b represents the estimates of the difference in mean symptom or function score for each course group compared to the remitted group
CI conﬁdence interval, PHQ patient health questionnaire, SF short form, MCS mental component summary, PCS physical component summary
a Time is in months between individual assessments
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time, which may suggest that depressive symptoms, somatic
symptoms,and mentalfunction are related.Since we didnot
have premorbid functioning data available, we were unable
to determine whether trait or scar effects were present [39].
Although we cannot conﬁrm the presence of a state effect
within the course groups, as all participants improved sig-
niﬁcantly over time, synchrony of change between severity
ofdepressivesymptomsandseverityofmentalfunctionmay
bepresent[39,40].Moreover,itispossiblethatsynchronyof
change between the severity of somatic symptoms and
severityofmentalfunctionalsoexists.Therefore,depressive
and somatic symptoms and mental function have to be
monitored closely in primary care patients diagnosed with
MDD as such surveillance could assist in the management
and possible prevention of chronic depression.
The results of this study suggest that although 43% of
patients with MDD attending primary care recover, this
leaves a majority of patients (57%) who have a chronic or
intermittent course. Persistence or chronicity of MDD is
associated with the severity of depressive and somatic
symptoms and mental dysfunction at baseline.
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